Skip to content

Author

Ming-Ming Yang

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Immunosenescence in Uveitis: From Mechanistic Insights to Therapeutic Implications.

Immunosenescence-the age-associated remodeling of the immune system-has emerged as a potential modifier of chronic inflammatory disease. This review examines the evidence that immunosenescence may contribute to the chronicity, refractoriness, and therapeutic heterogeneity of uveitis, and considers the clinical and tran...

Yi-Fei Wu, Ya-Ru Zou, Ming-Ming Yang et al. · 0 citations
Review Open access Sep 2026

Oxidative Stress and Uveitis: Molecular Mechanisms and Pathogenetic Role

Uveitis comprises a heterogeneous group of intraocular inflammatory diseases that differ in anatomical location, etiology, clinical course, and immune mechanisms. Despite this diversity, evidence derived predominantly from experimental autoimmune uveitis (EAU) suggests that oxidative stress may act as a context-depende...

Jia-Xin Deng, Ya-Ru Zou, Ming-Ming Yang et al. · 0 citations
Open access Sep 2026

Three-year Comparative Efficacy and Safety of Repeated Low-level Red-light Therapy and Orthokeratology for Myopia Control in Children.

INTRODUCTION Repeated low-level red-light therapy (RLRL) has emerged as a noninvasive intervention for myopia control in children. This study compared the 3-year efficacy and safety of RLRL and orthokeratology (OK). METHODS This retrospective study included 86 children treated with RLRL (n = 40) or OK (n = 46). The R...

Ai-Qin Nie, Jing Xie, Ying-Shi Zou et al. · 0 citations
Review Aug 2026

Cellular Senescence in Posterior Segment Neovascular Diseases: A Proposed Feed-Forward Amplification Model.

Neovascular age-related macular degeneration (nAMD) and proliferative diabetic retinopathy (PDR) continue to be significant contributors to permanent visual impairment. Although anti-vascular endothelial growth factor (anti-VEGF) therapy has substantially improved disease management, recurrent neovascularization, persi...

Yu-Mo Wang, Tian-Yi Luo, Cun-Zi Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.